Digestive Supplement Relesium Partnership Announced
The brands have teamed up to scale a supplement designed for those managing digestive side effects from GLP-1 medications.
Updated on Oct. 5, 2026 in Nutrition
Live Poll
Should companies market supplements to help manage the side effects of GLP-1 medications?
InterContinental Beverage Capital has partnered with PanTheryx to expand the availability of Relesium, a supplement formulated to target digestive discomfort. This effort aims to increase access for users of GLP-1 medications who experience common gastrointestinal side effects.
Why it matters
Managing digestive issues is a common hurdle for patients using GLP-1 drugs for metabolic health. This partnership aims to scale the distribution and product formats of Relesium to reach a wider population of these patients.
Research regarding the Relesium supplement has been published in the journal Nutrients. The findings highlight the ingredient composition, though further independent, large-scale clinical trials are needed to verify outcomes.
The players
InterContinental Beverage Capital
A New York-based investment firm that focuses on the beverage and consumer packaged goods industry.
PanTheryx
A Boulder, Colorado-based company specializing in colostrum-based health and nutrition products.
The details
Relesium features a blend of bovine colostrum and antibody-rich chicken egg powder to support digestive health. The new partnership between the firms focuses on identifying additional beverage and consumer packaged goods formats to integrate these ingredients. By leveraging InterContinental Beverage Capital's investment and management network, the companies intend to move the brand into new retail categories and markets.
Timeline
The partnership was formally announced on October 5, 2026.
Health Landscape
The expansion of Relesium reflects the ongoing market response to the widespread adoption of the GLP-1 receptor agonist medication class. It marks a downstream development in the ecosystem of supportive care products emerging to manage the side-effect profiles associated with these drugs.
If you are experiencing persistent digestive discomfort while taking GLP-1 medications, consult your physician before adding any new supplement to your routine. Always discuss how specific formulations might interact with your current prescriptions or existing gastrointestinal conditions.
The takeaway
As supportive care for GLP-1 usage grows, look for evidence-based ingredients when exploring digestive health aids. Always verify that any new supplement is safe for your individual health profile by scheduling a conversation with your healthcare provider.
Further reading
For more on managing the nutritional aspects of chronic health, visit our Nutrition section.
More information
Learn more about the formulation and company background on the PanTheryx company website.
Live Poll
Should companies market supplements to help manage the side effects of GLP-1 medications?
